Study Preserves Hopes for Roche ' s Tecentriq in Lung Cancer Study Preserves Hopes for Roche ' s Tecentriq in Lung Cancer

Swiss drugmaker Roche ' s hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form of lung cancer remained intact on Monday after a trial showed positive survival data.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news